Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,885 across all filing types
Latest filing 2022-10-19 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
关于回购股份注销完成暨股份变动的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the completion of a share repurchase cancellation and the resulting change in the company's share capital. It details the number of shares repurchased, the cancellation process, approvals by the board and shareholders, and the updated share capital structure. There are no financial statements or detailed financial performance data included. The document is focused on the company's own shares being repurchased and cancelled, which fits the category of a Transaction in Own Shares (POS). The document length is 2585 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is POS.
2022-10-19 Chinese
九芝堂股份有限公司简式权益变动报告书（壹号发展基金）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report". It details the change in shareholding percentage of an information disclosure obligor due to the company's share repurchase and cancellation, resulting in a passive increase in shareholding ratio without change in share quantity. The document includes detailed information about the shareholder, the nature of the shareholding change, legal references, and declarations. It is a formal report on changes in major shareholding levels, specifically noting the increase in shareholding percentage crossing the 5% threshold. There is no indication of it being an annual report, earnings release, or other financial report. It is clearly a notification of a major shareholding change as per regulatory requirements. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length (11850 characters) and content confirm it is the report itself, not just an announcement or certification.
2022-10-19 Chinese
关于新增关联方的日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the expected daily related-party transactions involving a newly added related party, Yifeng Pharmacy. It includes details about the nature of the transactions, approval by the board, independent directors' opinions, and financial data of the related party. The document is a formal disclosure about anticipated related-party transactions and their governance, not a full financial report or audit. It is not an annual or interim report, nor a call transcript or earnings release. It is a regulatory announcement about related-party transactions, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like Capital/Financing Update or Board/Management Information. The document length is under 5,000 characters, and it is a detailed announcement rather than a report publication notice or certification. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-09-29 Chinese
第八届董事会第十二次会议审议事项事前认可函
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the independent directors of a company regarding their prior approval of a board meeting agenda item related to anticipated related-party transactions. It references compliance with regulatory rules for independent directors and stock exchange listing rules. The content is about a pre-approval letter or statement from independent directors rather than a full report or financial statement. The document length is short (612 characters), and it does not contain financial data or detailed report content. It is not an annual report, audit report, earnings release, or any other detailed financial or management report. It is also not a voting result or a proxy solicitation. The document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement related to corporate governance and compliance but does not fit into more specific categories.
2022-09-29 Chinese
第八届董事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is titled as a resolution announcement from the company's eighth board of directors meeting. It details the meeting date, attendance, agenda items, voting results, and related procedural information. The content focuses on board decisions, specifically about related party transactions and changes in shareholding influence. There is no financial data, earnings information, or detailed report content. The document is an announcement of board meeting resolutions, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or presentation but a formal announcement of board decisions.
2022-09-29 Chinese
第八届董事会第十二次会议独立意见
Board/Management Information Classification · 95% confidence The document is a formal announcement from the company 九芝堂股份有限公司 regarding the independent directors' opinions on a specific board meeting agenda item about related party transactions. It references compliance with regulatory rules and the company's articles of association. The content is focused on governance and board-level decisions rather than financial results or reports. The document length is short (609 characters), and it does not contain financial statements or detailed financial data. It is not an announcement of voting results but an independent opinion on a board matter. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or opinions related to the board or senior management activities.
2022-09-29 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.